Tufts Lyme Disease Initiative receives $7M in grants to advance research to next level

Researchers at the Tufts Lyme Disease Initiative recently received grants totaling more than $7 million to build on an already impressive array of discoveries that Tufts’ teams have made to combat tick-borne diseases.

Formycon and Fresenius Kabi announce European Medicines Agency Submission Acceptance of the Marketing Authorization Application for FYB202, an Ustekinumab Biosimilar Candidate – Biotech Investments

EQS-News: Formycon AG / Key word(s): Regulatory Admission/Miscellaneous Formycon and Fresenius Kabi announce European Medicines Agency Submission Acceptance of the Marketing Authorization Application for FYB202,

September 30, 2023

What’s Next?— Predictions for What Happens After MDMA is Approved | Psychedelic Invest

The entire psychedelic industry is holding its breath in anticipation of the long-awaited FDA approval of MDMA. It will certainly be a big step for

June 22, 2023

Narcolepsy Symptoms Normalize With Novel Agent

A novel drug to supply the severe lack of brain orexin neuropeptides that characterizes narcolepsy type 1 showed major efficacy in a phase II study,

July 27, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.